Prothena(PRTA) - 2025 Q4 - Earnings Call Presentation

Prothena Fourth Quarter and Year-End 2025 Financial Results 4Q and FY25 Earnings Call Agenda | Welcome | Mark Johnson Vice President, Head of Investor Relations | | --- | --- | | Opening Remarks | Gene Kinney, Ph.D. President and CEO | | Clinical Programs | Chad Swanson, Ph.D. Chief Development Officer | | Preclinical Programs | Philip Dolan, Ph.D. Vice President, Head of Discovery Research | | Financial Results | Tran Nguyen Chief Strategy Officer and Chief Financial Officer | | Closing Remarks | Gene Kinn ...